Senate committee reviews H.545 amendments shifting 'recommended immunizations' authority to state commissioner; judiciary review sought on liability

The Senate Health & Welfare Committee on Feb. 10 reviewed a strike‑all amendment to H.545 that replaces references to CDC recommendations with recommendations issued by the Vermont Commissioner of Health and reorganizes pharmacy and vaccine advisory provisions.

Katie McDonough, legislative counsel, summarized the amendment’s three main changes: membership changes in the Vermont Immunization Advisory Council, a reworked pharmacy‑technician section defining when technicians may administer immunizations, and deletion of a duplicate pharmacy‑tech provision the House had sent. "This language takes effect on passage, and it sunsets. It goes away as of 07/01/2031," McDonough said, describing the bill’s staged effective dates.

Why it matters: the change shifts which body issues the authoritative list of "recommended immunizations" used in state statutes and insurance rules — a move that could affect who is authorized to administer vaccines, what insurers consider cost‑sharing exempt, and how liability protections apply.

Committee members pressed staff and department counsel on several practical points. The amendment authorizes the Department of Health to issue standing orders for recommended immunizations and provides narrow liability protection for health professionals who act in accordance with the commissioner’s recommendations. It also requires the Department to display information on the state’s recommended immunizations and to note where the commissioner’s recommendations differ from the advisory council’s advice.

Representative Burt, who testified as a proponent of stronger transparency and patient information, urged the committee to add clearer disclosures and a reporting requirement to cover potential gaps in federal compensation systems. He proposed language that any Department documents about recommended immunizations include a disclosure when state recommendations differ from federal guidance and that the commissioner report to the Senate Health & Welfare Committee where alignment with federal recommendations is not feasible and propose alternative remedies for affected individuals.

Department of Health general counsel Lauren Layman told senators that serious vaccine injuries are very rare. "Based on federal government data, about 1 in 1,000,000 vaccines administered every year end up with compensation," Layman said, adding that the department cannot replicate the federal Vaccine Injury Compensation Program (VICP) but will try to preserve access and transparency for patients.

Pharmacy changes: the amendment keeps pharmacist authority to prescribe and administer recommended immunizations for patients 5 years and older (including influenza and COVID‑19 formulations) and limits pharmacy technicians so they may administer immunizations only when a licensed pharmacist trained to immunize is present and able to assist, and when acting under a valid prescription, a standing order by the commissioner, or a commissioner‑approved protocol.

Insurance implications: sections that currently eliminate cost‑sharing when immunizations are CDC‑recommended would be amended so cost‑sharing is avoided when immunizations are recommended by the Commissioner of Health, preserving consumer coverage parity despite the change in recommending authority.

Next steps: the committee declined to vote on H.545 on Feb. 10 and asked Senator Hashim’s committee to review the bill’s liability sections. Chair said the committee will reconvene for a vote once judiciary provides guidance.

The committee’s review focused on maintaining access, preserving scientifically based decision making and ensuring clear public information if state recommendations diverge from federal guidance.